3218 Stock Overview
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 3218 from our risk checks.
Universal Vision Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$236.00 |
| 52 Week High | NT$412.74 |
| 52 Week Low | NT$236.00 |
| Beta | 0.63 |
| 1 Month Change | -14.34% |
| 3 Month Change | -16.16% |
| 1 Year Change | -36.10% |
| 3 Year Change | -11.41% |
| 5 Year Change | 778.49% |
| Change since IPO | 1,217.36% |
Recent News & Updates
Recent updates
Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 03
The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?
Mar 26Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 08The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention
Feb 07Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 17
Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly
Dec 27Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)
Dec 06Shareholder Returns
| 3218 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | -7.8% | -4.6% | -5.7% |
| 1Y | -36.1% | -12.2% | 23.8% |
Return vs Industry: 3218 underperformed the TW Healthcare industry which returned -12.2% over the past year.
Return vs Market: 3218 underperformed the TW Market which returned 23.8% over the past year.
Price Volatility
| 3218 volatility | |
|---|---|
| 3218 Average Weekly Movement | 4.3% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.5% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 3218's share price has been volatile over the past 3 months.
Volatility Over Time: 3218's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Pi-Jung Lin | www.uvb.com.tw/ |
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Its clinic provides laser vision correction surgery for myopia, hyperopia, astigmatism, and presbyopia; intraocular lens surgery for presbyopia and cataract; phacoemulsification and femtosecond laser for cataract surgery; and myopia control services, as well as services for dry eyes, retinal detachment, macular degeneration, strabismus, amblyopia, and other eye diseases. The company also offers vision products and services, including a range of eyeglass frames, multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, regular/colored contact lenses, eye supplements, etc.; eye plastic and micro cosmetic surgery; and customized aesthetic medicine consulting.
Universal Vision Biotechnology Co., Ltd. Fundamentals Summary
| 3218 fundamental statistics | |
|---|---|
| Market cap | NT$20.00b |
| Earnings (TTM) | NT$1.05b |
| Revenue (TTM) | NT$4.08b |
19.1x
P/E Ratio4.9x
P/S RatioIs 3218 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3218 income statement (TTM) | |
|---|---|
| Revenue | NT$4.08b |
| Cost of Revenue | NT$1.63b |
| Gross Profit | NT$2.45b |
| Other Expenses | NT$1.40b |
| Earnings | NT$1.05b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.34 |
| Gross Margin | 59.98% |
| Net Profit Margin | 25.60% |
| Debt/Equity Ratio | 0.3% |
How did 3218 perform over the long term?
See historical performance and comparison